Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Salaries and benefits

Supplies

Other operating expenses

Equity in earnings of affiliates

Depreciation and amortization

Interest expense

Gains on sales of facilities

Losses on retirement of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

HCA Healthcare

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

HCA Healthcare reports robust Q4 performance and outlines strategic growth

HCA Healthcare's Q4 2022 performance reflects strong same-facility volumes, stable labor costs, and strategic investments in growth areas.
The company's focus on overcoming challenges, leveraging strengths, and seizing opportunities positions them for sustainable growth and operational excellence.
With a clear agenda for 2023, including revenue guidance and investment plans, HCA Healthcare aims to navigate market dynamics and drive value creation.
By addressing key performance metrics, managing costs effectively, and pursuing strategic initiatives, HCA Healthcare demonstrates a commitment to long-term success.

HCA Healthcare reports robust Q1 earnings amidst operational enhancements

HCA Healthcare delivered strong financial performance with notable growth in key metrics and operational efficiency improvements.
While facing challenges from COVID-related impacts and procedural shifts, the company is focused on maintaining positive volume trends and managing costs effectively.
Opportunities lie in investing in capabilities, capacity improvement, and navigating contract renewals in an inflationary environment.

HCA Healthcare reports robust Q2 earnings amidst strategic investments

HCA Healthcare's Q2 2023 performance reflects strong earnings, revenue growth, and cash flow, supported by strategic investments.
While facing challenges like margin impact from acquisitions and rising capital spending, the company is well-positioned for growth.
Opportunities lie in optimizing labor costs, expanding services, and leveraging positive payer mix trends for sustained success.
Overall, HCA's focus on quality care, financial prudence, and growth initiatives underpins a positive outlook for the future.

HCA Healthcare manages challenges, eyes sustained growth amid revenue optimizations

HCA Healthcare navigated challenges from the Valesco venture to deliver solid financial performance. The company's focus on quality care, cost management, and revenue optimization positions it for sustained growth. Anticipation of improved margins, strategic growth discussions, and operational enhancements highlight a positive outlook for the future.

HCA Healthcare reports robust Q4 earnings and outlines growth strategies

HCA Healthcare's strong Q4 performance and strategic investments position it well for growth in 2024, with a focus on cost management and operational efficiency.
The company's confidence in navigating industry challenges, coupled with initiatives to drive value and improve patient outcomes, underpin its optimistic outlook for the future.
With a clear focus on growth drivers like Medicare Advantage admissions and revenue per equivalent admission, HCA Healthcare is poised for a promising year ahead.

HCA Healthcare posts robust Q1 earnings, eyes sustained growth opportunities

HCA Healthcare's Q1 2024 performance reflects strong financial results and operational efficiency, supported by favorable same-facility volumes and effective cost management. While facing challenges in outpatient cases, the company is well-positioned to capitalize on opportunities for growth.
Strategic investments in infrastructure, technology, and campus integration are strengthening HCA Healthcare's operational capabilities and market positioning. Monitoring Medicaid statuses and potential procedure rebounds are key focus areas for the company.

HCA Healthcare reports robust Q2 earnings amidst market challenges

HCA Healthcare's Q2 2024 performance reflects strong financial growth, driven by increased revenues and improved margins.
While challenges like managing capital expenditures persist, opportunities in payer mix optimization and market demand offer avenues for further growth.
The company's ability to navigate evolving market dynamics and capitalize on strategic opportunities will be key to sustaining its positive momentum.

HCA Healthcare reports resilient Q3 results amid hurricane challenges

HCA Healthcare's Q3 performance showcased resilience amidst hurricane challenges, with strong volume and revenue growth.
Investments in network expansion and technology underscore the company's commitment to quality care and operational efficiency.
While challenges from hurricanes persist, HCA Healthcare sees opportunities for earnings growth and value creation in the near future.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Spotify

Now looks like a promising time to invest in the increased profitability of HCA Healthcare (HCA) and Spotify Technology (SPOT) after beating Q2 earnings expectations on Tuesday.

2 Standout Stocks to Buy After Beating Earnings Expectations

HCA Healthcare (HCA) shares jumped to an all-time high Tuesday after the health-care services provider posted better-than-expected earnings and boosted its guidance, as the company reported bringing in more patients.

HCA Healthcare Stock Price Hits All-Time High as Earnings Top Estimates

HCA Healthcare (HCA) increases its 2024 EPS in the range of $21.60-$22.8, the midpoint implying growth of 17% from the 2023 figure.

HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2024 EPS View

HCA Healthcare, Inc. (NYSE:HCA ) Q2 2024 Results Conference Call July 23, 2024 10:00 AM ET Company Participants Frank Morgan - Vice President of Investor Relations Sam Hazen - Chief Executive Officer Mike Marks - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Ann Hynes - Mizuho Securities Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Ben Hendrix - RBC Capital Markets Justin Lake - Wolfe Research Whit Mayo - Leerink Partners Andrew Mok - Barclays Stephen Baxter - Wells Fargo Scott Fidel - Stephens Jason Cassorla - Citigroup Kevin Fischbeck - Bank of America Ryan Langston - TD Cowen John Ransom - Raymond Sarah James - Cantor Fitzgerald Operator Welcome to the HCA Healthcare Second Quarter 2024 Earnings Conference Call.

HCA Healthcare, Inc. (HCA) Q2 2024 Earnings Call Transcript

Although the revenue and EPS for HCA (HCA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, HCA (HCA) Q2 Earnings: A Look at Key Metrics

HCA Healthcare (HCA) came out with quarterly earnings of $5.50 per share, beating the Zacks Consensus Estimate of $4.97 per share. This compares to earnings of $4.29 per share a year ago.

HCA Healthcare (HCA) Surpasses Q2 Earnings and Revenue Estimates

HCA Healthcare jumped into a buy zone on strong earnings and guidance. Rival hospital chains also made bullish moves ahead of their results.

HCA Healthcare Jumps Back Into Buy Zone On Earnings, Guidance; Rivals Also Up

Hospital giant raises full-year guidance amid growth in admissions, inpatient surgeries

HCA's stock surges as hospital operator's quarterly results top expectations

HCA Healthcare raised its annual profit forecast on Tuesday, after beating Wall Street estimates for quarterly earnings, sending shares of the hospital operator up nearly 7% before the bell.

HCA Healthcare raises annual profit forecast on strong demand for medical care

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2024. Key second quarter metrics (all percentage changes compare 2Q 2024 to 2Q 2023 unless otherwise noted): Revenues totaled $17.492 billion Net income attributable to HCA Healthcare, Inc. totaled $1.461 billion, or $5.53 per diluted share Adjusted EBITDA totaled $3.550 billion Cash flows from operating activities totaled $1.971 billion Same.

HCA Healthcare Reports Second Quarter 2024 Results

Here is how HCA Healthcare (HCA) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.

Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?

AutoNation

Dick's Sporting Goods

Group 1 Automotive

Liberty Broadband

LyondellBasell Industries

Robert Half Int.

Ryanair Hlds

Conventum - Alluvium Global Fund ended the quarter with 19 holdings and 15.3% cash. The fund bought AutoNation, Ryanair, Robert Half and Liberty Broadband. The fund sold LyondellBasell, DICK'S Sporting and HCA Healthcare.

Conventum - Alluvium Global Fund's Q2 2024 Buys And Sells

HCA Healthcare, Inc. will report earnings on Tuesday, July 23rd. I expect HCA to have a strong quarter based on reaffirmed guidance, industry trends, and consensus revisions upward. Multiple valuation methods signal HCA is fairly priced, while industry trends suggest balanced upside and downside. I continue to rate HCA a hold.

HCA Healthcare Q2 Earnings Preview: Cost And Margin In Focus

Cigna

Tenet Healthcare

Universal Health Services

Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.

4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates

HCA Healthcare's (HCA) second-quarter earnings are likely to benefit from improved admissions and payer mix, partially offset by rising operating expenses.

Can HCA Healthcare (HCA) Beat Q2 Earnings on Growing Admissions?

HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HCA Healthcare (HCA) Reports Next Week: Wall Street Expects Earnings Growth

Vertex Pharmaceuticals

These healthcare businesses are booming. Vertex Pharmaceuticals is raking in approvals, cash, and profits.

Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever

Abbott Labs

Gilead Sciences

Medtronic

Novartis

Pfizer

Over the years, especially the past three, I have become more cautious about the technology sector's blatant overvaluation. Nevertheless, it is difficult to ignore the capabilities of companies such as Nvidia (NASDAQ: NVDA ) and their innovative solutions for AI.

The 7 Most Undervalued Healthcare Stocks to Buy in July 2024

CVS Health

DexCom

UnitedHealth Group

The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging population, technological advances, and rising healthcare costs provide the sector with a compelling combination of growth potential and resilience.

Top 4 Must-Have Healthcare Stocks for Long-Term Growth

Apple

Churchill Downs

JPMorgan Chase & Co

Expro Group Holdings NV

Apple (AAPL), HCA Healthcare (HCA), Expro International (XPRO), Churchill Downs (CHDN) and JPMorgan Chase (JPM) could make great plays as the second-quarter earnings season unfolds.

5 Stocks Worth a Look From Leading Sectors This Earnings Season

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q Earnings Release Call When: Tuesday, July 23, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet:   https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call wil.

HCA Healthcare, Inc. 2nd Quarter 2024 Earnings Conference Call

Elevance Health Inc

McKesson

The healthcare sector is often considered a defensive play, with healthcare stocks to buy offering stability and growth potential even during economic downturns. The sector's strength is driven by an aging global population, rising healthcare expenditures, and advancements in medical technology.

The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits

Encompass Health

Fundamentally, the case for strong buy healthcare stocks really sells itself. First off, let's discuss the underlying sector.

Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024

HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and solid cash-generating abilities.

Compelling Reasons to Hold on to HCA Healthcare (HCA) Stock

Johnson & Johnson

These two healthcare leaders have impressive track records of longevity and success. Both companies still have qualities that should allow them to deliver strong returns.

News for HCA Healthcare Stock (HCA)